Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII

BACKGROUND: Hemophilia A is a bleeding disorder caused by deficiency in coagulation factor VIII. Recombinant factor VIII (rFVIII) is an alternative to plasma-derived FVIII for the treatment of hemophilia A. However, commercial manufacturing of rFVIII products is inefficient and costly and is associa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Swiech, Kamilla, Kamen, Amine, Ansorge, Sven, Durocher, Yves, Picanço-Castro, Virgínia, Russo-Carbolante, Elisa MS, Neto, Mário SA, Covas, Dimas T
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3254136/
https://ncbi.nlm.nih.gov/pubmed/22115125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6750-11-114
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars